Remus Pharmaceuticals dividend history and dates
NSE: REMUSPharmaceuticals & Biotechnology
Share price at the NSE close on 23 Oct 2026. Previous close ₹901.20.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹1,038 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 20 May 2026
- 28.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 3.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.11%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 20 May 2026
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 20 May 2026
- 13.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,80085.7% delivered
Next dividend, ex-date and record date
No dividend is announced. The last went ex on 22 Sep 2026: ₹0.50 a share.
All upcoming dividends ›Remus Pharmaceuticals dividend calendar
Each payment in the month it went ex, as declared, ₹ a share at the time. Years running counted to the year to Mar 2026.
- Paid 4 years running, from the year to Mar 2023Paid years running. Consecutive years ending here in which a dividend was declared, counted from 2007.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | In the year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | ₹0.50 | ₹0.50 | |||||||||||
| 2025 | ₹0.50 | ₹0.50 | Not added up | ||||||||||
| 2024 | ₹4.00 | ₹1.00 | Not added up | ||||||||||
| 2023 | ₹2.00 | ₹2.00 | ₹4.00 |
Interim or final dividendSpecial dividendNone that month
Dividends by year
Per share, for the year it was paid for: a dividend declared with a year's results counts in that year, even when it goes ex after the year ends.Remus Pharmaceuticals bonus share history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.Share of profit paid out, %, where the year's results are on record
Dividend payout. Dividends per share on the year end's share count × shares in issue ÷ profit to the company's own shareholders for the year × 100, on the consolidated accounts, which cover the group with its subsidiaries; empty where that year's results are not on record, show a loss or have no share count, and for a row that is not a full year.Remus Pharmaceuticals dividend history
Every payment with its ex-date and record date, the latest years open.
2026
- Sep22Tue
₹0.50FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held.
Ex-date and record date 22 Sep 2026 · announced 20 May 2026
0.05%of the price
2025
- Nov14Fri
₹0.50Interim
Ex-date and record date 14 Nov 2025 · announced 10 Nov 2025
0.07%of the price - Sep18Thu
₹0.50FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held.
Ex-date and record date 18 Sep 2025
0.06%of the price
Earlier, 2023 to 2024
2024
- Nov19Tue
₹1.00Interim
Ex-date 19 Nov 2024 · record date 20 Nov 2024
0.04%of the price - May2Thu
₹4.00Interim
Ex-date and record date 2 May 2024 · announced 23 Apr 2024
0.05%of the price
2023₹4.00 a share in 2 payments
- Oct27Fri
₹2.00Interim
Ex-date 27 Oct 2023 · record date 28 Oct 2023 · announced 19 Oct 2023
0.04%of the price - Sep15Fri
₹2.00FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held.
Ex-date and record date 15 Sep 2023
0.05%of the price
Grouped by the calendar year each went ex, so a year's total here can differ from the year it was paid for above. Of the price is the dividend as a share of the close on the session before its ex-date.